drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Brainwaves of Mothers and Children Synchronize During Play, Even in an Acquired Language
A UK research team reported in "Frontiers in Cognition" that brain activity (neural synchrony) between bilingual mothers and their 3-4 year-old children synchronizes equally during play, whether they communicate in the mother's native language or an acquired second language (English). This neural synchrony, crucial for parent-child bonding and communication, was particularly strong in the prefrontal cortex during interactive play. The findings suggest that using a second language does not hinder the brain-to-brain connection between parents and children, emphasizing that bilingualism can support healthy communication and learning.
Bioengineered Silk, Window-Cleaning Robots, and Anti-Bacterial Enzymes: Open Innovation Weekly 28.01.26
Springwise's "Open Innovation Weekly" highlights key innovations this week. Germany's AMSilk has incorporated bioengineered silk into Balenciaga's collection, while US startup Electrified Thermal Solutions launched its first commercial thermal battery for industrial heat. In Japan, the Sakura Deeptech Shibuya Accelerator, backed by Tokyu Land Corporation, fosters startups like window-cleaning robot developers, and Narita International Airport is establishing an innovation hub. Mitsubishi Heavy Industries is partnering with Institut Teknologi Bandung on ammonia fuel research, and the University of Valencia has spun out a company to develop antibacterial enzymes for food safety, addressing antibiotic resistance. These initiatives demonstrate contributions to sustainability, efficiency, and health.
Printable enzyme ink powers next-generation wearable biosensors
A research team led by Associate Professor Isao Shitanda at Tokyo University of Science (TUS) has developed water-based 'enzyme inks' that simplify the fabrication of enzymatic biofuel cells (EBFCs) into a single screen-printing step, overcoming longstanding barriers to mass-producing self-powered wearable biosensors. Conventional EBFC manufacturing requires multiple labor-intensive steps—printing carbon electrodes, drop-casting enzyme and mediator solutions, and drying—resulting in high variability and impractical scalability. The new ink formulation combines magnesium oxide-templated mesoporous carbon, chemical mediators, a novel water-based polymer binder (POLYSOL), and carboxymethyl cellulose as a thickener, with specific enzymes such as lactate oxidase or glucose dehydrogenase added depending on the target analyte. Crucially, all components are dispersed in water to preserve enzyme activity. Printed electrodes significantly outperformed drop-cast counterparts, maintaining stable performance over extended periods. A complete lactate/oxygen biofuel cell achieved a maximum power output of 165 μW/cm², surpassing the 96 μW/cm² of prior systems. The team has already demonstrated self-powered wireless lactate monitoring via Bluetooth Low Energy, and validated roll-to-roll printing over 400 m of substrate—pointing toward production costs as low as approximately 10 yen per device. Practical implementation is targeted for around 2030, with potential applications in sports performance monitoring, elderly care, and heatstroke prevention.
Development of an analytical method for evaluating and analyzing the microbial degradation of marine biodegradable plastics - Expecting acceleration of product development and promotion of understanding of marine biodegradation
NITE has developed a new analytical method to efficiently evaluate and analyze the microbial degradation of marine biodegradable plastics. This method combines the measurement of carbon dioxide in the gas phase with the analysis of decomposition products in the liquid phase, enabling efficient biodegradability assessment of multiple samples and detailed analysis of degradation patterns. This is expected to accelerate the development of new materials and products, enhance understanding of microbial relationships in plastic-surface ecosystems (plastisphere), and accumulate knowledge on marine biodegradation mechanisms, thus contributing to the development of novel marine biodegradable plastics.
Top Biotech Startups 2026: An Analysis of Emerging Trends
This analysis identifies 20 emerging biotech startups poised to make major impacts by 2026, including companies tackling critical health issues such as Hera Biotech for endometriosis diagnosis and RAGE Biotech for chronic lung diseases, advanced platform technologies like Andson Biotech for mass spectrometry and LatchBio for cloud bioinformatics, environmental solutions including Entomal converting food waste via insects and HydRegen pioneering green catalysts, and novel therapeutics such as Tune Therapeutics' gene therapy for hepatitis B and SpliceBio's intein-based gene splice platform.
Canon Commercializes World's First Wafer Planarization Technology Applying Nanoimprint Lithography, Dramatically Improving Flatness Required for Advanced Semiconductor Manufacturing
Canon has commercialized the world's first wafer planarization technology, "Inkjet-based Adaptive Planarization (IAP)," applying nanoimprint lithography (NIL). This technology precisely places planarization material via inkjet and presses a flat glass plate, achieving flatness of less than 5nm across a 300mm wafer. This dramatically improves critical dimension (CD) errors and pattern misalignment in advanced semiconductor manufacturing, enhancing yield and productivity. Canon aims to commercialize equipment utilizing this technology by 2027.
Iktos Enters Strategic Partnership Exceeding €1 Billion with Servier for AI Drug Discovery in Oncology and Neurological Diseases
Iktos, a leading company in AI and robotics for drug discovery, has signed a multi-target collaborative research agreement with Servier, an independent international pharmaceutical company, in the fields of oncology and neurological diseases. This multi-year agreement, valued at over €1 billion, will leverage Iktos's generative AI and AI-driven robotics platforms to accelerate the design and optimization of new small-molecule therapeutics. Servier will evaluate compounds using proprietary biological assays and oversee preclinical and clinical development. This partnership aims to combine Iktos's advanced technology with Servier's drug discovery expertise to contribute to the advancement of personalized medicine and create innovative therapeutic drugs.
Scientists Made This Lung-on-a-Chip Breathe. Then They Gave It TB.
Scientists have developed a new "lung-on-a-chip" model using only genetically identical cells derived from human stem cells to unravel the early stages of tuberculosis (TB) and the peculiar delay before symptom onset. This model allows for detailed observation of interactions between immune cells and TB bacteria, suggesting implications for understanding how genetic variations in patients affect TB and for personalized medicine. The study identified macrophage cluster formation and lung dysfunction after infection, as well as the role of the ATG14 gene. This technology is expected to contribute to the development of personalized treatments for TB and other infections.
Germaine de Capuccini launches Expert Lab Tec-Exosomes – bringing regenerative spa results to your home
Luxury skincare brand Germaine de Capuccini has unveiled its 'Expert Lab Tec-Exosome System,' an advanced regenerative skincare innovation. Utilizing plant-derived exosomes and proprietary TECXOSOME™ technology, this at-home system aims to reactivate cellular communication for long-term improvements in skin firmness, texture, hydration, and radiance. Containing over 5 trillion exosomes per 1ml, it is designed to bring professional regenerative spa results to the home.
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Vivos Therapeutics and SoundHealth announced a collaboration to expand access to SoundHealth's innovative FDA-cleared allergy and sleep technologies. Through Vivos' extensive network of dentists and sleep healthcare providers, products like the Sonu® Band for nasal congestion and the Spatial Sleep™ band for promoting deep sleep will be distributed. These devices utilize AI and vibro-acoustic neuromodulation to address underlying causes of breathing-related sleep disorders, including sleep apnea.
Artificial metabolism turns waste CO2 into useful chemicals
Northwestern and Stanford engineers have developed an artificial metabolic system, named Reductive Formate Pathway (ReForm), that converts waste CO2 into valuable chemicals like acetyl-CoA and malate. This synthetic biology breakthrough uses engineered enzymes to perform non-natural metabolic reactions outside living cells, addressing challenges in carbon recycling and the urgent need for carbon-negative manufacturing. The cell-free system allowed rapid screening of thousands of enzyme variants, paving the way for sustainable fuels and materials from diverse carbon sources like formate, formaldehyde, and methanol.
Anzen Industries Raises $1.7 Million in Pre-Seed Funding for Cell-Free Biomanufacturing
Anzen Industries has secured £1.7 million ($2.2 million) in pre-seed funding to accelerate the development and commercialization of its innovative cell-free biomanufacturing platform for producing high-value chemicals. Unlike traditional methods that rely on living cells, Anzen's approach uses enzyme systems operating outside of cells. This technology aims to revolutionize the production of pharmaceuticals, diagnostics, and other industrial products, enabling faster and more cost-effective manufacturing processes.
Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable
Jurek Kozyra, CEO of Nanovery, is revolutionizing molecular medicine with DNA nanorobots that could cure previously incurable diseases. These self-assembling machines, combining DNA nanotechnology and AI, dramatically reduce diagnostic times from days to hours and accelerate drug development, potentially shortening the decade-long journey for life-saving treatments. DNA nanorobots can detect diseases in blood samples within 2-4 hours, demonstrating equivalent or better accuracy than traditional tests in clinical settings, marking a significant breakthrough for rapid diagnostics in emergency situations.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Brainwaves of Mothers and Children Synchronize During Play, Even in an Acquired Language
A UK research team reported in "Frontiers in Cognition" that brain activity (neural synchrony) between bilingual mothers and their 3-4 year-old children synchronizes equally during play, whether they communicate in the mother's native language or an acquired second language (English). This neural synchrony, crucial for parent-child bonding and communication, was particularly strong in the prefrontal cortex during interactive play. The findings suggest that using a second language does not hinder the brain-to-brain connection between parents and children, emphasizing that bilingualism can support healthy communication and learning.
EurekAlert!
Bioengineered Silk, Window-Cleaning Robots, and Anti-Bacterial Enzymes: Open Innovation Weekly 28.01.26
Springwise's "Open Innovation Weekly" highlights key innovations this week. Germany's AMSilk has incorporated bioengineered silk into Balenciaga's collection, while US startup Electrified Thermal Solutions launched its first commercial thermal battery for industrial heat. In Japan, the Sakura Deeptech Shibuya Accelerator, backed by Tokyu Land Corporation, fosters startups like window-cleaning robot developers, and Narita International Airport is establishing an innovation hub. Mitsubishi Heavy Industries is partnering with Institut Teknologi Bandung on ammonia fuel research, and the University of Valencia has spun out a company to develop antibacterial enzymes for food safety, addressing antibiotic resistance. These initiatives demonstrate contributions to sustainability, efficiency, and health.
Springwise
Printable enzyme ink powers next-generation wearable biosensors
A research team led by Associate Professor Isao Shitanda at Tokyo University of Science (TUS) has developed water-based 'enzyme inks' that simplify the fabrication of enzymatic biofuel cells (EBFCs) into a single screen-printing step, overcoming longstanding barriers to mass-producing self-powered wearable biosensors. Conventional EBFC manufacturing requires multiple labor-intensive steps—printing carbon electrodes, drop-casting enzyme and mediator solutions, and drying—resulting in high variability and impractical scalability. The new ink formulation combines magnesium oxide-templated mesoporous carbon, chemical mediators, a novel water-based polymer binder (POLYSOL), and carboxymethyl cellulose as a thickener, with specific enzymes such as lactate oxidase or glucose dehydrogenase added depending on the target analyte. Crucially, all components are dispersed in water to preserve enzyme activity. Printed electrodes significantly outperformed drop-cast counterparts, maintaining stable performance over extended periods. A complete lactate/oxygen biofuel cell achieved a maximum power output of 165 μW/cm², surpassing the 96 μW/cm² of prior systems. The team has already demonstrated self-powered wireless lactate monitoring via Bluetooth Low Energy, and validated roll-to-roll printing over 400 m of substrate—pointing toward production costs as low as approximately 10 yen per device. Practical implementation is targeted for around 2030, with potential applications in sports performance monitoring, elderly care, and heatstroke prevention.
EurekAlert! / Tokyo University of Science
Development of an analytical method for evaluating and analyzing the microbial degradation of marine biodegradable plastics - Expecting acceleration of product development and promotion of understanding of marine biodegradation
NITE has developed a new analytical method to efficiently evaluate and analyze the microbial degradation of marine biodegradable plastics. This method combines the measurement of carbon dioxide in the gas phase with the analysis of decomposition products in the liquid phase, enabling efficient biodegradability assessment of multiple samples and detailed analysis of degradation patterns. This is expected to accelerate the development of new materials and products, enhance understanding of microbial relationships in plastic-surface ecosystems (plastisphere), and accumulate knowledge on marine biodegradation mechanisms, thus contributing to the development of novel marine biodegradable plastics.
製品評価技術基盤機構 (NITE)
Top Biotech Startups 2026: An Analysis of Emerging Trends
This analysis identifies 20 emerging biotech startups poised to make major impacts by 2026, including companies tackling critical health issues such as Hera Biotech for endometriosis diagnosis and RAGE Biotech for chronic lung diseases, advanced platform technologies like Andson Biotech for mass spectrometry and LatchBio for cloud bioinformatics, environmental solutions including Entomal converting food waste via insects and HydRegen pioneering green catalysts, and novel therapeutics such as Tune Therapeutics' gene therapy for hepatitis B and SpliceBio's intein-based gene splice platform.
IntuitionLabs
Canon Commercializes World's First Wafer Planarization Technology Applying Nanoimprint Lithography, Dramatically Improving Flatness Required for Advanced Semiconductor Manufacturing
Canon has commercialized the world's first wafer planarization technology, "Inkjet-based Adaptive Planarization (IAP)," applying nanoimprint lithography (NIL). This technology precisely places planarization material via inkjet and presses a flat glass plate, achieving flatness of less than 5nm across a 300mm wafer. This dramatically improves critical dimension (CD) errors and pattern misalignment in advanced semiconductor manufacturing, enhancing yield and productivity. Canon aims to commercialize equipment utilizing this technology by 2027.
Canon (キヤノン株式会社)
Iktos Enters Strategic Partnership Exceeding €1 Billion with Servier for AI Drug Discovery in Oncology and Neurological Diseases
Iktos, a leading company in AI and robotics for drug discovery, has signed a multi-target collaborative research agreement with Servier, an independent international pharmaceutical company, in the fields of oncology and neurological diseases. This multi-year agreement, valued at over €1 billion, will leverage Iktos's generative AI and AI-driven robotics platforms to accelerate the design and optimization of new small-molecule therapeutics. Servier will evaluate compounds using proprietary biological assays and oversee preclinical and clinical development. This partnership aims to combine Iktos's advanced technology with Servier's drug discovery expertise to contribute to the advancement of personalized medicine and create innovative therapeutic drugs.
PR TIMES
Scientists Made This Lung-on-a-Chip Breathe. Then They Gave It TB.
Scientists have developed a new "lung-on-a-chip" model using only genetically identical cells derived from human stem cells to unravel the early stages of tuberculosis (TB) and the peculiar delay before symptom onset. This model allows for detailed observation of interactions between immune cells and TB bacteria, suggesting implications for understanding how genetic variations in patients affect TB and for personalized medicine. The study identified macrophage cluster formation and lung dysfunction after infection, as well as the role of the ATG14 gene. This technology is expected to contribute to the development of personalized treatments for TB and other infections.
ScienceAlert
Germaine de Capuccini launches Expert Lab Tec-Exosomes – bringing regenerative spa results to your home
Luxury skincare brand Germaine de Capuccini has unveiled its 'Expert Lab Tec-Exosome System,' an advanced regenerative skincare innovation. Utilizing plant-derived exosomes and proprietary TECXOSOME™ technology, this at-home system aims to reactivate cellular communication for long-term improvements in skin firmness, texture, hydration, and radiance. Containing over 5 trillion exosomes per 1ml, it is designed to bring professional regenerative spa results to the home.
Retail Times
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Vivos Therapeutics and SoundHealth announced a collaboration to expand access to SoundHealth's innovative FDA-cleared allergy and sleep technologies. Through Vivos' extensive network of dentists and sleep healthcare providers, products like the Sonu® Band for nasal congestion and the Spatial Sleep™ band for promoting deep sleep will be distributed. These devices utilize AI and vibro-acoustic neuromodulation to address underlying causes of breathing-related sleep disorders, including sleep apnea.
GlobeNewswire
Artificial metabolism turns waste CO2 into useful chemicals
Northwestern and Stanford engineers have developed an artificial metabolic system, named Reductive Formate Pathway (ReForm), that converts waste CO2 into valuable chemicals like acetyl-CoA and malate. This synthetic biology breakthrough uses engineered enzymes to perform non-natural metabolic reactions outside living cells, addressing challenges in carbon recycling and the urgent need for carbon-negative manufacturing. The cell-free system allowed rapid screening of thousands of enzyme variants, paving the way for sustainable fuels and materials from diverse carbon sources like formate, formaldehyde, and methanol.
Northwestern University
Anzen Industries Raises $1.7 Million in Pre-Seed Funding for Cell-Free Biomanufacturing
Anzen Industries has secured £1.7 million ($2.2 million) in pre-seed funding to accelerate the development and commercialization of its innovative cell-free biomanufacturing platform for producing high-value chemicals. Unlike traditional methods that rely on living cells, Anzen's approach uses enzyme systems operating outside of cells. This technology aims to revolutionize the production of pharmaceuticals, diagnostics, and other industrial products, enabling faster and more cost-effective manufacturing processes.
The Techfounders
Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable
Jurek Kozyra, CEO of Nanovery, is revolutionizing molecular medicine with DNA nanorobots that could cure previously incurable diseases. These self-assembling machines, combining DNA nanotechnology and AI, dramatically reduce diagnostic times from days to hours and accelerate drug development, potentially shortening the decade-long journey for life-saving treatments. DNA nanorobots can detect diseases in blood samples within 2-4 hours, demonstrating equivalent or better accuracy than traditional tests in clinical settings, marking a significant breakthrough for rapid diagnostics in emergency situations.
PR Newswire